Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm-Reference-Cited by-同舟云学术

Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm

Published:2018-01-25 Issue:4 Volume:23 Page:305-314
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Sanguedolce Francesca¹,Brunelli Matteo²,D’amuri Alessandro³,Calò Beppe⁴,Mancini Vito⁴,Carrieri Giuseppe⁴,Cormio Luigi⁴

Affiliation:

1. Department of Pathology, University of Foggia, Foggia, Italy;

2. Department of Pathology and Diagnostic, University of Verona, Verona, Italy;

3. Anatomic Pathology, Card. G. Panico Hospital, Tricase, Italy;

4. Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2018.1428360

Reference98 articles.

1. The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study

2. Epithelial-Stromal Interface in Normal and Neoplastic Human Bladder Epithelium

3. An Approach to the Diagnosis of Flat Intraepithelial Lesions of the Urinary Bladder Using the World Health Organization/ International Society of Urological Pathology Consensus Classification System

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role;International Journal of Molecular Sciences;2023-02-13

2. Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression;International Journal of Molecular Sciences;2022-07-15

3. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?;Pathology - Research and Practice;2022-06

4. Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?;Current Drug Targets;2020-12-31

5. Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin;World Journal of Urology;2020-02-15